Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRCH4 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
mRNA | CNTNAP1 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
mRNA | PCDH18 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | GABRA1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | HNMT | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | MSRB3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | TRPC1 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
mRNA | EFEMP2 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
mRNA | GHDC | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | CTNNBIP1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |